Find the Right Market Report
Search thousands of industry reports, market insights, and research studies in one place.
Search thousands of industry reports, market insights, and research studies in one place.
Stay ahead of the curve with in-depth coverage of the latest breakthroughs, emerging trends, strategic developments, and transformative innovations shaping the future of healthcare, science, technology, and global business.
01 December 2025
Announcement GE Healthcare proudly confirmed that it has earned the FDA Premarket Authorisation for its modern 3D mammography image reconstruction technology, Pristina Recon DL. This commendable tec...
01 December 2025
Announcement Hemostemix Inc. is delighted to read out the bond letter of its plant for beginning with the first two cardiology practices via acquisition strategy, inspired by the Company’s int...
01 December 2025
Announcement TempraMed Technologies Ltd., a Canada-based leading company, has entered a particular exclusive commercial distribution partnership with Guri A.A.O. to sell and promote (market) TempraM...
01 December 2025
Announcement After the FDA approved Otsuka’s anti-APRIL antibody sibeprenlimab to alleviate the urine protein level in the IgA nephropathy patient group, this approved drug will be commerciali...
28 November 2025
Announcement FUJIFILM Healthcare Americas Corporation, a pioneering champion in enterprise and diagnostic imaging solutions, will be ramping up its current diagnostic imaging innovations in the Sout...
28 November 2025
Announcement Pasithea Therapeutics Corp., a leading clinical-level biotechnology company establishing a next-generation macrocyclic MEK inhibitor, PAS-004, is delighted to announce that its PAS-004 ...
28 November 2025
Announcement Phio Pharmaceuticals Corp., a clinical-level siRNA biopharmaceutical company establishing a therapeutic game with its exclusive INTASYL® gene silencing technology to treat cancer, h...
28 November 2025
Announcement Novartis’ intrathecal form of spinal muscular atrophy gene therapy, Zolgensma, received FDA approval. With this approval, Novartis will expand access to this therapy, reaching pat...
27 November 2025
Announcement Thermo Fisher Scientific Inc. declared that it has listed the pricing of the €2.1 billion offerings, estimated principal amount of the euro-denominated senior notes. This will be re...
27 November 2025
Announcement Bristol Myers Squibb proudly confirmed that they have officially received a European Commission’s approval stamp on Breyanzi® potential, a CD19-directed chimeric antigen recept...
Speak with a healthcare analyst about your research, consulting, or platform needs.